Viktoría Werkström

机构：AstraZeneca (Finland), AstraZeneca (Spain)

发表论文 52 篇 · 总被引 4168 次 · h-index 18

代表论文

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial (2021 · Journal of Allergy and Clinical Immunology · 被引 322)
Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals (2018 · Respiratory Research · 被引 41)
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety ( TATE study) (2024 · Pediatric Allergy and Immunology · 被引 33)
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial (2024 · European Respiratory Journal · 被引 25)
Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma (2019 · Allergy Asthma and Immunology Research · 被引 24)
Clinical Efficacy of Benralizumab in Patients With Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials (2018 · Journal of Allergy and Clinical Immunology · 被引 22)